BPC-157 and Erectile Dysfunction Erectile dysfunction is attributable to several different causes, classified as vasculogenic, psychogenic, endocrinologic, or neurologic
Studies have also indicated interactions with opioid pathways DSIP administration has been shown to modulate pain perception and has effects that can be partially blocked by opioid antagonists in some paradigms, suggesting opioidergic involvement in at least some of its actions
Peptides are potent, and a small error in reconstitution or drawing the solution can lead to a 10-20% dose error
Despite its importance, maintaining optimal levels can be challenging, particularly for those with dietary restrictions or absorption issues
Given BPC-157's apparent pro-angiogenic effects (VEGF upregulation), a theoretical concern about promotion of tumor vascularization exists and has not been ruled out by long-term animal studies
Hufig lsst sich erst nach Akteneinsicht beurteilen, welche konkrete Strafbarkeit berhaupt im Raum steht
